{"title":"Multimodal management of eruptive squamous atypia in a patient with chronic immunosuppression.","authors":"Michael Anderson, Mia Harris, Tiffany Mayo","doi":"10.25251/765j8m50","DOIUrl":"https://doi.org/10.25251/765j8m50","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Implementation of quality improvement and root cause analyses in dermatology.","authors":"Dina Collins, Jason Miller","doi":"10.25251/qft9zx50","DOIUrl":"https://doi.org/10.25251/qft9zx50","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aaron Cheng, Jose Gaspar de Alba, Corinne Daise, Steven Daveluy, James Q Del Rosso, Victoria G Farley, Graham Litchman
{"title":"Ending diagnostic delay begins in the classroom: Rethinking hidradenitis suppurativa education.","authors":"Aaron Cheng, Jose Gaspar de Alba, Corinne Daise, Steven Daveluy, James Q Del Rosso, Victoria G Farley, Graham Litchman","doi":"10.25251/9vd05470","DOIUrl":"https://doi.org/10.25251/9vd05470","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Caleb J Beckham, Alhasan Altayf, Kritin K Verma, Michelle B Tarbox, Daniel P Friedmann
{"title":"Safety information and adverse event profiles of home laser hair removal devices: A commercial website analysis.","authors":"Caleb J Beckham, Alhasan Altayf, Kritin K Verma, Michelle B Tarbox, Daniel P Friedmann","doi":"10.25251/5g51kk07","DOIUrl":"https://doi.org/10.25251/5g51kk07","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Camille Moeckel, Elen Deng, Alice Lin, Matthew F Helm, Sara B Ferguson
{"title":"Trauma-induced keratoacanthomas following skin cancer excisions.","authors":"Camille Moeckel, Elen Deng, Alice Lin, Matthew F Helm, Sara B Ferguson","doi":"10.25251/6jak4671","DOIUrl":"https://doi.org/10.25251/6jak4671","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of preventive skin moisturization for dermatological adverse events caused by apalutamide: A retrospective study at 2 facilities in Japan.","authors":"Natsuo Kimura, Keisuke Hata, Yoshiyasu Amiya, Takayuki Shima, Noriyuki Suzuki, Hiroomi Nakatsu","doi":"10.25251/4dmwat50","DOIUrl":"10.25251/4dmwat50","url":null,"abstract":"<p><strong>Background: </strong>Apalutamide is an androgen receptor antagonist used to treat patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) or metastatic castration-sensitive prostate cancer (mCSPC). One of the most frequent adverse events associated with apalutamide is skin rash, particularly in Japanese patients. However, preventive skin care may reduce the frequency of apalutamide-induced skin rashes.</p><p><strong>Objective: </strong>We sought to compare the cumulative incidence of skin rashes in patients on apalutamide therapy with and without preventive skin care.</p><p><strong>Methods: </strong>This retrospective, real-world study included 27 patients in the control group (those who were not administered skin care) and 38 patients in the skin care group (those who were administered preventative skin care).</p><p><strong>Results: </strong>After a median follow-up of 7 months, grade 3 apalutamide-induced skin rashes occurred in 8.1% (3/37) of patients in the skin care group and 53.6% (15/28) of patients in the control group. Based on Gray's test, the difference in incidence between groups was statistically significant (<i>P</i> = .002).</p><p><strong>Conclusion: </strong>Preventive skin moisturization may reduce apalutamide-induced adverse skin events in patients with mCSPC or nmCRPC. Incorporating routine skin care may help patients experience the full efficacy of apalutamide while maintaining a good quality of life.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An evidence-based low-allergen product list for the general dermatologist.","authors":"Brailyn Weber, Sarah Karels, Anne Neeley","doi":"10.25251/2tbx0k40","DOIUrl":"https://doi.org/10.25251/2tbx0k40","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Margaret Y Huang, Kimberly Smart, Kathryn Lee, Paige Kingston, Danielle Yee, Hannah Peterson, Edwin Korouri, April W Armstrong
{"title":"Vitiligo in the United States: A 10-year study of patient characteristics, comorbidities, and treatment patterns.","authors":"Margaret Y Huang, Kimberly Smart, Kathryn Lee, Paige Kingston, Danielle Yee, Hannah Peterson, Edwin Korouri, April W Armstrong","doi":"10.25251/39x13b67","DOIUrl":"https://doi.org/10.25251/39x13b67","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francisco Javier Gómez Ballesta, Mariel Cecilia Paternina Álvarez, Ana Isabel Betancourt Benítez, María José Montiel Salas, Sergio Armando López Bermúdez, Juan Pablo Alzate Granados
{"title":"Efficacy and safety of emerging immunomodulatory agents versus standard therapies in refractory cutaneous lupus: A systematic review.","authors":"Francisco Javier Gómez Ballesta, Mariel Cecilia Paternina Álvarez, Ana Isabel Betancourt Benítez, María José Montiel Salas, Sergio Armando López Bermúdez, Juan Pablo Alzate Granados","doi":"10.25251/52gar039","DOIUrl":"10.25251/52gar039","url":null,"abstract":"<p><strong>Background: </strong>Refractory cutaneous lupus (RCL) remains challenging to treat, with limited response to standard therapies. Emerging immunomodulatory agents, including thalidomide, lenalidomide, anifrolumab, belimumab, and intravenous immunoglobulin, may offer improved outcomes.</p><p><strong>Objective: </strong>To evaluate the efficacy and safety of emerging immunomodulatory agents in adults with RCL.</p><p><strong>Methods: </strong>A systematic review was conducted following PRISMA guidelines. Randomized controlled trials evaluating the efficacy and safety of the specified agents in adults with RCL were included. Databases searched included MEDLINE, Embase, and LILACS. Primary outcomes were CLASI, BICLA, and SRI-4 response rates. Secondary outcomes included adverse events and quality of life.</p><p><strong>Results: </strong>Anifrolumab achieved CLASI-50 in up to 63.0% of patients versus 30.8% with placebo and BICLA response in up to 53.5% versus 25.7%. Belimumab improved SRI-4 response to 43.2% versus 33.5% with placebo. RSLV-132 and tofacitinib demonstrated partial efficacy. Herpes zoster was more frequent with anifrolumab.</p><p><strong>Conclusion: </strong>Anifrolumab and belimumab provide superior efficacy with acceptable safety in RCL, supporting their inclusion in personalized treatment algorithms.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148600017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}